Immunoprophylaxis: Available effective vaccines (ICRC from Mumbai and HKML+BCG of WHO) are still to be considered for public health program (Gupte et al 1998, Indian J. Leprosy)

Chemoprophylaxis: Limited experience in selected population using Rifampicin alone or in combination with Ofloxacin and Minocycline is available for further study.

Immunotherapy: Needs further experience.

Healthy carriers: Looking into this areas may be necessary during low endemic phase to develop Eradication model.